Diffuse lewy body disease

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current Treatment Options in Neurology

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11940-001-0013-XPMID 11581527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD

  2001cited by this paper
• Synucleinopathies: clinical and pathological implications.

  2001cited by this paper
• 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies

  2000cited by this paper
• Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies.

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• Activated microglia in dementia with Lewy bodies

  2000cited by this paper
• Physiology and Pathophysiology of α‐Synuclein: Cell Culture and Transgenic Animal Models Based on a Parkinson's Disease‐associated Protein

  2000cited by this paper
• Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial

  2000influential reference
• Golf ball epilepsy

  2000cited by this paper
• Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia

  2000cited by this paper
• Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases.

  2000cited by this paper
• Donepezil for behavioural disorders associated with Lewy bodies: a case series

  2000cited by this paper
• Treatment of REM sleep behavior disorder with donepezil: A report of three cases

  2000cited by this paper
• Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

  2000cited by this paper
• Acetylcholinesterase Inhibition in Dementia with Lewy Bodies: Results of a Prospective Pilot Trial

  2000cited by this paper
• Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

  2000cited by this paper
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

  2000cited by this paper
• The pathology of REM sleep behavior disorder with comorbid Lewy body dementia.

  2000cited by this paper
• Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt–Jakob disease

  2000cited by this paper
• Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

  2000cited by this paper
• Cholinergic dysfunction in diseases with Lewy bodies

  2000cited by this paper
• Pramipexole‐induced somnolence and episodes of daytime sleep

  2000cited by this paper
• Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.

  1999cited by this paper
• White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging

  1999cited by this paper
• Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

  1999cited by this paper
• Physical aggression in dementia patients and its relationship to depression.

  1999cited by this paper
• Diabetes mellitus and the risk of dementia

  1999cited by this paper
• Olanzapine in dementia with Lewy bodies: a clinical study

  1999cited by this paper
• EEG findings in dementia with Lewy bodies and Alzheimer’s disease

  1999cited by this paper
• Report of the second dementia with Lewy body international workshop

  1999cited by this paper
• REM sleep behavior disorder and dementia

  1999cited by this paper
• Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer’s disease

  1999cited by this paper
• Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy‐verified sample

  1999cited by this paper
• Diagnosing dementia with Lewy bodies.

  1999influential reference
• Regional cerebral blood flow difference between dementia with Lewy bodies and AD

  1999cited by this paper
• Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia

  1999cited by this paper
• Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies

  1999cited by this paper
• REM sleep behavior disorder and degenerative dementia

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease.

  1998cited by this paper
• Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients

  1998cited by this paper
• Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease

  1998influential reference
• Hemianopsia in dementia with Lewy bodies.

  1998cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• Tacrine efficacy in Lewy body dementia

  1998cited by this paper
• Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

  1998cited by this paper
• A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?

  1998cited by this paper
• Dementia with Lewy bodies

  1998cited by this paper
• Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease

  1998cited by this paper
• Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease.

  1998cited by this paper
• Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse lewy body disease and 34 pathologically confirmed cases of parkinson's disease

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease

  1996cited by this paper
• Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder

  1996cited by this paper
• Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease. Do the parkinsonian features differ?

  1996cited by this paper
• Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease

  1996cited by this paper
• Psychiatric features in diffuse Lewy body disease

  1996cited by this paper
• Dementia with Lewy bodies

  1996cited by this paper
• Neuroleptic sensitivity to risperidone in Lewy body dementia.

  1995influential reference
• Parkinsonian features of eight pathologically diagnosed cases of diffuse lewy body disease

  1995cited by this paper
• Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

  1995cited by this paper
• Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.

  1994cited by this paper
• Lewy bodies and response to tacrine in Alzheimer's disease.

  1994cited by this paper
• DRD2 Ser311/Cys311 polymorphism in schizophrenia

  1994cited by this paper
• Tacrine for senile dementia of Alzheimer's or Lewy body type.

  1994cited by this paper
• Preventing biliary stent occlusion

  1994cited by this paper
• Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly.

  1993cited by this paper
• A comparative study of attentional deficits in senile dementias of Alzheimer and lewy body types

  1992cited by this paper
• Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

  1992influential reference
• Incontinence and Troublesome Behaviors Predict Institutionalization in Dementia

  1992cited by this paper
• Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease

  1991cited by this paper
• Diffuse Lewy body disease: the clinical features.

  1990cited by this paper
• Diffuse Lewy body disease and progressive dementia

  1988cited by this paper
• Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

  1987cited by this paper
• [A cliniconeurophathological study of the "Lewy body disease"].

  1980cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• AN ESSAY ON THE SHAKING PALSY

  1969cited by this paper
• DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION

  1961cited by this paper
• Paralysis agitans. I. Pathologische Anatomie

  year unknowncited by this paper

• Autophagy in α-Synucleinopathies—An Overstrained System

  2021cites this paper
• Dementia with Lewy Bodies

  2019cites this paper
• Lewy Body Disease

  2019cites this paper
• Toward personalized treatment of hallucinations

  2018cites this paper
• Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein

  2017cites this paper
• A 63-Year-Old Man with Lewy Body Dementia and Multiple Symptoms

  2015cites this paper
• Energy dysfunction in Huntington's disease: insights from PGC-1a, AMPK, and CKB

  2012cites this paper
• Energy dysfunction in Huntington’s disease: insights from PGC-1α, AMPK, and CKB

  2012cites this paper
• Differential Diagnosis of Dementia with Lewy Bodies and Alzheimer Disease Using Combined MR Imaging and Brain Perfusion Single-Photon Emission Tomography

  2010cites this paper
• Musical Hallucinations and Parkinson Disease

  2009cites this paper
• Themenschwerpunkt: Probleme der Pharmakotherapie bei der Demenz mit Lewy-Körperchen

  2008cites this paper
• Vascular dementia: Pharmacological treatment approaches and perspectives

  2007cites this paper
• Sleep and Neurologic Problems in the Elderly

  2006cites this paper
• Kapitel 50 - Demenzen

  2005cites this paper
• Visual hallucinations

  2004cites this paper
• Hétérogénéité de la maladie de Parkinson

  2003cites this paper
• Uso de la quetiapina en la demencia con cuerpos de Lewy: a propósito de un caso

  2002cites this paper